Proteopedia:What's New: Difference between revisions
Jump to navigation
Jump to search
Taya O'Neill (talk | contribs) No edit summary |
Eric Martz (talk | contribs) No edit summary |
||
(42 intermediate revisions by 9 users not shown) | |||
Line 1: | Line 1: | ||
<center><table width="90%" cellpadding="10" style="background-color:#ffffc0;border:1px solid gray"><tr><td> | |||
<big> | |||
This page has not been maintained since 2013, so it is now merely historical record. | |||
<br><br> | |||
To see what is new, please visit [[Special:Newpages]], which is automatically generated, and includes the pages for new PDB entries seeded by the OCA robot as well as pages authored by users. To find pages on a particular subject, use the <b>search</b> slot at left. | |||
</big></td></tr></table></center><br> | |||
<big><b>What's New in Proteopedia?</b></big> | <big><b>What's New in Proteopedia?</b></big> | ||
<br> | <br> | ||
Line 12: | Line 19: | ||
<br><br> | <br><br> | ||
The left arrow symbol (<-) signifies a page that [[Help:Editing#Redirecting_One_Page_to_Another_Page|redirects]] to another page. | The left arrow symbol (<-) signifies a page that [[Help:Editing#Redirecting_One_Page_to_Another_Page|redirects]] to another page. | ||
<br><br> | |||
<font color="red">Because this page is maintained manually, the lists for recent months are usually incomplete. There are typically other new articles that are not yet listed.</font> You may also wish to consult [[Topic pages]] (also maintained manually); [[Special:Newpages]] which is automatically generated, but includes the pages for new PDB entries seeded by the OCA robot; or [[Special:Allpages/a| all pages whose titles do not begin with a numeral]] (thus excluding pages titled with PDB codes, but not limited to new pages). | |||
</div> | </div> | ||
---- | ---- | ||
== April, 2010 == | ==2013== | ||
===December 2013=== | |||
*Major change to [[Chymotrypsin]] | |||
*Major addition to [[RuBisCO]] | |||
===October 2013=== | |||
*[[ABA Signaling Pathway]] | |||
*[[PYR/PYL/RCAR family of ABA receptors]] | |||
*[[ABA-regulated SNRK2 Protein Kinase]] | |||
*[[PYR/PYL/RCAR family of ABA receptors]] | |||
===September 2013=== | |||
* [[Eukaryotic Protein Kinase Catalytic Domain]] | |||
*[[Calcium-dependent protein kinase]] | |||
*[[EF hand]] | |||
==2012== | |||
===May 2012=== | |||
* [[Renin]] | |||
==2011== | |||
===May, 2011=== | |||
* [[RNase A]] | |||
* [[RNase A Oligomers]] | |||
* [[RNase A NMR]] | |||
* [[RNaseA Nobel Prizes]] | |||
* [[RNaseS RNaseB]] | |||
===April, 2011=== | |||
*[[CASP]] | |||
*[[Homology modeling]] | |||
*[[Homology modeling servers]] | |||
===March, 2011=== | |||
*[[Lac repressor]] has been updated to incorporate new understanding of interactions of proteins with the minor groove of DNA. | |||
*[[Nitrotyrosine]], a post-translational modification occurring in inflammation that often inactivates enzymes. | |||
*[[Java]] | |||
==2010== | |||
=== October, 2010 === | |||
*[[Psi and Phi Angles]], Identifies the atoms which make up these angles, illustrates how Jmol can be used to determine their values and by drawing planes illustrates how their values are set by rotating the plane of the peptide bonds and the alpha-carbons and the atoms bonded to them. | |||
===July, 2010=== | |||
*[[Glutamate receptor (GluA2)|Glutamate Receptor]] | |||
===June, 2010=== | |||
*[[Metal-Ligand Polyhedra]]: Mixtures of certain metal ions with bent bidentate ligands self-assemble into large polygons that can be functionalized to serve as receptors, nanoreactors, etc. | |||
=== May, 2010 === | |||
*[[Rhodopsin]] | |||
=== April, 2010 === | |||
*[[Green Fluorescent Protein]], significant additions have been made to this page. | |||
*[[NADPH Cytochrome P450 Oxidoreductase]] | *[[NADPH Cytochrome P450 Oxidoreductase]] | ||
*[[Proteopedia:Twitter]] - Proteopedia is now on Twitter. '''Follow us at [http://twitter.com/proteopedia Proteopedia on Twitter]'''. | |||
*[[Pore forming toxin, α-hemolysin|The pore forming toxin, α-hemolysin]] | |||
== March, 2010 == | === March, 2010 === | ||
*[[Serine Proteases | *[[Serine Proteases]], examines the structural basis of specificity and a general properties of the catalytic mechanism | ||
== January, 2010 == | === January, 2010 === | ||
*[[Archaeal Histones]], illustrates the structural features of two histones and a dimer of one of them. | *[[Archaeal Histones]], illustrates the structural features of two histones and a dimer of one of them. | ||
*[[Syn and anti nucleosides]], illustrates the structural differences in the syn and anti configurations of nucleosides. | *[[Syn and anti nucleosides]], illustrates the structural differences in the syn and anti configurations of nucleosides. | ||
*[[Ramachandran Plots]], this page is a copy of User:Karl Oberholser/Ramachandran Plots which is a protected page. | *[[Ramachandran Plots]], this page is a copy of User:Karl Oberholser/Ramachandran Plots which is a protected page. | ||
*[[ | *[[LepA|''Escherichia coli'' LepA, the ribosomal back translocase]] | ||
==December, 2009== | ==2009== | ||
===December, 2009=== | |||
''This month's list is incomplete:'' | ''This month's list is incomplete:'' | ||
*[[User:Wayne Decatur/Interactions between Antibiotics and the Ribosome|Interactions between Antibiotics and the Ribosome]] | *[[User:Wayne Decatur/Interactions between Antibiotics and the Ribosome|Interactions between Antibiotics and the Ribosome]] | ||
*[[ | *[[Large Ribosomal Subunit of Haloarcula|Large Ribosomal Subunit of ''Haloarcula marismortui'']] <!-- This links now to the public page that was made in May 2010 from the page completed in a user space in December 2009--> | ||
*[[User:Wayne_Decatur/Haloarcula Large Ribosomal Subunit With Azithromycin|Azithromycin bound to the Large Ribosomal Subunit of Haloarcula]] | *[[User:Wayne_Decatur/Haloarcula Large Ribosomal Subunit With Azithromycin|Azithromycin bound to the Large Ribosomal Subunit of Haloarcula]] | ||
*[[Reverse transcriptase]] | *[[Reverse transcriptase]] | ||
==November, 2009== | ===November, 2009=== | ||
''This month's list is incomplete:'' | ''This month's list is incomplete:'' | ||
*[[1gm5|RecG in complex with a synthetic three-way DNA junction resembling a stalled replication fork]] | *[[1gm5|RecG in complex with a synthetic three-way DNA junction resembling a stalled replication fork]] | ||
*[[3ews|DExD/H-box RNA-dependent ATPase DDX19 in the open]] and [[3g0h|closed]] cleft conformation | *[[3ews|DExD/H-box RNA-dependent ATPase DDX19 in the open]] and [[3g0h|closed]] cleft conformation | ||
==October, 2009== | ===October, 2009=== | ||
''This month's list is incomplete:'' | ''This month's list is incomplete:'' | ||
*[[Ribosome]], also featured at the [[Main Page]], since its structures won the [[Nobel Prizes for 3D Molecular Structure|Nobel Prize in Chemistry]] this month! | *[[Ribosome]], also featured at the [[Main Page]], since its structures won the [[Nobel Prizes for 3D Molecular Structure|Nobel Prize in Chemistry]] this month! | ||
Line 46: | Line 111: | ||
*[[Proteopedia:Guidelines for Ethical Writing]] | *[[Proteopedia:Guidelines for Ethical Writing]] | ||
==July, 2009== | ===July, 2009=== | ||
''This month's list is incomplete:'' | ''This month's list is incomplete:'' | ||
*[[Influenza hemagglutinin]] | *[[Influenza hemagglutinin]] | ||
*The 21st and 22nd amino acids were added to [[Amino Acids]]: namely [[Selenocysteine]] and [[Pyrrolysine]]. | *The 21st and 22nd amino acids were added to [[Amino Acids]]: namely [[Selenocysteine]] and [[Pyrrolysine]]. | ||
==March, 2009== | ===March, 2009=== | ||
''This month's list is incomplete:'' | ''This month's list is incomplete:'' | ||
*[[Mechanosensitive channels: opening and closing]] includes morphs of the ion-conducting channel opening and closing. | *[[Mechanosensitive channels: opening and closing]] includes morphs of the ion-conducting channel opening and closing. | ||
Line 57: | Line 122: | ||
*[[Richards, Frederic M.]] (1925-2009) including a photo of "Fred's Folly". | *[[Richards, Frederic M.]] (1925-2009) including a photo of "Fred's Folly". | ||
==February, 2009== | ===February, 2009=== | ||
''This month's list is incomplete:'' | ''This month's list is incomplete:'' | ||
*[[Ion channels]] is an attempt to cover a family of proteins and list their available PDB structures. | *[[Ion channels]] is an attempt to cover a family of proteins and list their available PDB structures. | ||
==January, 2009== | ===January, 2009=== | ||
''This month's list is incomplete:'' | ''This month's list is incomplete:'' | ||
==December, 2008== | ==2008== | ||
===December, 2008=== | |||
*[[Conservation, Evolutionary]] now includes instructions on how to show a ConSurf result as a scene in Proteopedia, complete with the standard ConSurf color key. | *[[Conservation, Evolutionary]] now includes instructions on how to show a ConSurf result as a scene in Proteopedia, complete with the standard ConSurf color key. | ||
*[[Resolution]] now includes a movie illustrating the relation between the atomic model and the electron density map while resolution ranges from 0.5 to 5.0 Ångstroms. | *[[Resolution]] now includes a movie illustrating the relation between the atomic model and the electron density map while resolution ranges from 0.5 to 5.0 Ångstroms. | ||
==November, 2008== | ===November, 2008=== | ||
*[[Suppression of RNA Silencing by Viruses|RNA silencing: suppression by viruses]]. Concerns the research awarded the [http://nobelprize.org/nobel_prizes/medicine/laureates/2006/ 2006 Nobel Prize in Physiology or Medicine]. Linked are new pages on specific RNA silencing proteins: [[Plant Viral Protein p19 Suppression of RNA Silencing|Plant viral protein p19]], [[Tomato aspermy virus protein 2b Suppression of RNA Silencing|Tomato aspermy virus protein 2b]], and [[Flock house virus B2 protein Suppression of RNA Silencing|Flock house virus B2 protein]]. | *[[Suppression of RNA Silencing by Viruses|RNA silencing: suppression by viruses]]. Concerns the research awarded the [http://nobelprize.org/nobel_prizes/medicine/laureates/2006/ 2006 Nobel Prize in Physiology or Medicine]. Linked are new pages on specific RNA silencing proteins: [[Plant Viral Protein p19 Suppression of RNA Silencing|Plant viral protein p19]], [[Tomato aspermy virus protein 2b Suppression of RNA Silencing|Tomato aspermy virus protein 2b]], and [[Flock house virus B2 protein Suppression of RNA Silencing|Flock house virus B2 protein]]. | ||
*[[Transcription Termination Factor Rho]]. | *[[Transcription Termination Factor Rho]]. | ||
Line 76: | Line 142: | ||
*[[Molecular modeling and visualization software]], whick links to new pages on [[PyMOL]], [[Jmol]], [[RasMol]], and [[Chime]]. | *[[Molecular modeling and visualization software]], whick links to new pages on [[PyMOL]], [[Jmol]], [[RasMol]], and [[Chime]]. | ||
==October, 2008== | ===October, 2008=== | ||
*[[Lac repressor]] structure, including a morph of the DNA-binding domain bending the operator DNA. | *[[Lac repressor]] structure, including a morph of the DNA-binding domain bending the operator DNA. | ||
*Poly(A) Polymerase, [[2q66]]: A new section complementing this month's article in [[Molecule of the Month]]. | *Poly(A) Polymerase, [[2q66]]: A new section complementing this month's article in [[Molecule of the Month]]. | ||
Line 92: | Line 158: | ||
*Several pages about visualization software: [[FirstGlance in Jmol]], [[Swiss-PDBViewer = DeepView]], and [[Protein Explorer]]. | *Several pages about visualization software: [[FirstGlance in Jmol]], [[Swiss-PDBViewer = DeepView]], and [[Protein Explorer]]. | ||
==September, 2008== | ===September, 2008=== | ||
*Anticancer Prodrug CPT-11 complexed with ''Torpedo californica'' Acetylcholinesterase [[1u65]] | *Anticancer Prodrug CPT-11 complexed with ''Torpedo californica'' Acetylcholinesterase [[1u65]] | ||
*[[Avian Influenza Neuraminidase, Tamiflu and Relenza]] | *[[Avian Influenza Neuraminidase, Tamiflu and Relenza]] | ||
Line 102: | Line 168: | ||
*[[User:Tom Gluick/glutamine synthetase|Glutamine Synthetase]], which includes instructions on how to use the Jmol console for advanced scene authoring. | *[[User:Tom Gluick/glutamine synthetase|Glutamine Synthetase]], which includes instructions on how to use the Jmol console for advanced scene authoring. | ||
==August, 2008== | ===August, 2008=== | ||
*[[HIV-1 protease]] | *[[HIV-1 protease]] | ||
*[[Pyruvate phosphate dikinase]] with a morph of the catalytic reaction and conformational changes. | *[[Pyruvate phosphate dikinase]] with a morph of the catalytic reaction and conformational changes. | ||
*[[Enzyme I of the Phosphoenolpyruvate:Sugar Phosphotransferase System]] with a morph of the catalytic reaction and conformational changes. | *[[Enzyme I of the Phosphoenolpyruvate:Sugar Phosphotransferase System]] with a morph of the catalytic reaction and conformational changes. | ||
*[[Antizyme Inhibitor]] | *[[Antizyme Inhibitor]] | ||
*Selenocysteine Synthase, [[SelB | *Selenocysteine Synthase, [[SelB]] is a new page complementing this month's article in [[Molecule of the Month]]. | ||
*[[Teaching Strategies Using Proteopedia]] | *[[Teaching Strategies Using Proteopedia]] | ||
*[[User:J._Shaun_Lott/BIOSCI_203|Protein structure lesson plan for BioSci 203]] | *[[User:J._Shaun_Lott/BIOSCI_203|Protein structure lesson plan for BioSci 203]] | ||
*[[Proteopedia: News]] | *[[Proteopedia: News]] | ||
==July, 2008== | ===July, 2008=== | ||
*[[Biotin Protein Ligase]] | *[[Biotin Protein Ligase]] | ||
*YAGE, A Prophage Protein Belonging To The Dihydrodipicolinic Acid Synthase Family From E. Coli K12, [[2v9d]]. | *YAGE, A Prophage Protein Belonging To The Dihydrodipicolinic Acid Synthase Family From E. Coli K12, [[2v9d]]. | ||
Line 121: | Line 187: | ||
*[[Student Projects]] | *[[Student Projects]] | ||
==June 2008== | ===June 2008=== | ||
*Computational design of a Kemp elimination catalyst [[2rkx]]. | *Computational design of a Kemp elimination catalyst [[2rkx]]. | ||
*[[Recoverin, a calcium-activated myristoyl switch]] | *[[Recoverin, a calcium-activated myristoyl switch]] | ||
Line 149: | Line 215: | ||
*[[Unit cell]] | *[[Unit cell]] | ||
==May 2008== | ===May 2008=== | ||
*[[Acetylcholinesterase]] | *[[Acetylcholinesterase]] | ||
*[[2ace]] with an overview of the significance of this, the first acetylcholinesterase structure. | *[[2ace]] with an overview of the significance of this, the first acetylcholinesterase structure. | ||
Line 161: | Line 227: | ||
*[[Help:Copying FirstGlance Scenes into Proteopedia]] | *[[Help:Copying FirstGlance Scenes into Proteopedia]] | ||
==April 2008== | ===April 2008=== | ||
*Acetylcholinesterase inhibited by nerve agent soman [[1som]]. | *Acetylcholinesterase inhibited by nerve agent soman [[1som]]. | ||
*Highest resolution acetylcholinesterase so far, [[1ea5]]. | *Highest resolution acetylcholinesterase so far, [[1ea5]]. | ||
Line 172: | Line 238: | ||
*[[Help:Protected Pages]] | *[[Help:Protected Pages]] | ||
==March 2008== | ===March 2008=== | ||
*Conformational flexibility in the peripheral site of Torpedo californica acetylecholinesterase revealed by the complex structure with a bifunctional inhibitor, [[2cek]]. | *Conformational flexibility in the peripheral site of Torpedo californica acetylecholinesterase revealed by the complex structure with a bifunctional inhibitor, [[2cek]]. | ||
*[[Proton Channels]] | *[[Proton Channels]] | ||
Line 179: | Line 245: | ||
*[[SGAP]] Streptomyces griseus Aminopeptidase (SGAP) (''no Jmol'') | *[[SGAP]] Streptomyces griseus Aminopeptidase (SGAP) (''no Jmol'') | ||
==February 2008== | ===February 2008=== | ||
*[[Hemoglobin]] | *[[Hemoglobin]] | ||
*[[Highest impact structures]] of all time. | *[[Highest impact structures]] of all time. | ||
Line 188: | Line 254: | ||
*[[Personal favorites]] | *[[Personal favorites]] | ||
==January 2008== | ===January 2008=== | ||
*[[AChE inhibitors and substrates]] | *[[AChE inhibitors and substrates]] | ||
*[[Dihydrofolate reductase]] | *[[Dihydrofolate reductase]] | ||
==October-December 2007== | ==2007== | ||
===October-December 2007=== | |||
*[[Serine Protease]] | *[[Serine Protease]] | ||
*[[Nqo1]] NADH quinone oxidoreductase (NQO1) in complex with its potent inhibitor dicoumarol. | *[[Nqo1]] NADH quinone oxidoreductase (NQO1) in complex with its potent inhibitor dicoumarol. |